Changing of the guard at board

Mark Beeston, chief operating officer for OTC derivatives at Deutsche Bank; Richard Cohen, a managing director at Bank of America; Drew Gross, a managing director at JP Morgan Chase; David Long, chief operating officer for developed market rates at Credit Suisse First Boston; and Ardavan Nozari, a managing director at Citigroup, have all joined the board as representatives of their respective banks.

"These new directorships represent a 'passing of portfolio' within their respective companies," said Philippe Khuong-Huu, a Goldman Sachs managing director and chairman of "The board is comprised of senior derivatives business leaders from major market participants... [who] volunteer their time to set overall goals, priorities and direction for financial products mark-up language within the OTC derivatives trading industry."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here